Company
Software for the people who live with autoimmune disease, the clinicians who treat it and the researchers who study it. Built in Madrid.
Autoimmune disease reaches patients, clinicians and researchers. Neural Omega builds for all three, on one scientific foundation.
Each vertical has its own audience and its own products. The science and the principles beneath them are shared.
A private ecosystem where people living with autoimmune disease and the clinicians who treat them own a clinical picture that moves with them.
Infrastructure for new studies, discovery through molecular mimicry and our own research lines in advanced therapies.
Leadership sets the direction from Madrid. Engineering builds the products.
Medical graduate and researcher in immunology and molecular mimicry, whose own research is the origin of the company. Architect of the technical platform, now leading strategy, execution and direction across both verticals.
LinkedInLeads Neural Omega's ethics, bioethics and corporate responsibility framework, from principles to practice. Keeps the science accountable to patients, professionals and industry partners as the company grows across both verticals.
LinkedInComputer scientist with extensive experience leading technical projects. Builds the native Apple apps of Neural Omega, from iOS to iPadOS, macOS and visionOS.
The facts behind Neural Omega, and where its science and its ethics are set out in full.
The line of inquiry behind every product, with the evidence and the references that support it.
The four principles of medical ethics, applied to data, AI and research.
Neural Omega grows in phases. The first, combining private and public capital, is complete.
Neural Omega has received financing from ENISA, Ministry of Industry and Tourism, funded by the European Union – NextGenerationEU under the Recovery, Transformation and Resilience Plan.
Clinicians, researchers, patient organisations, partners and investors are welcome to start a conversation.